Merrimack Pharmaceuticals

-$0.27 (-3.98%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MACK and other stocks, options, and ETFs commission-free!

About MACK

Merrimack Pharmaceuticals, Inc. Common Stock, also called Merrimack Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer.

CEO
Gary L. Crocker
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
1993

MACK Key Statistics

Market Cap
90.27M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
37.01K
High Today
$6.71
Low Today
$6.39
Open Price
$6.71
Volume
31.76K
52 Week High
$9.45
52 Week Low
$3.06

MACK Earnings

-$0.21
-$0.13
-$0.06
$0.02
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 18, After Hours

You May Also Like

CXE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure